Tiago Marques - Dec 20, 2021 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Tiago Reis Marques
Stock symbol
KTTA
Transactions as of
Dec 20, 2021
Transactions value $
$0
Form type
4
Date filed
12/22/2021, 04:00 PM
Previous filing
Sep 14, 2021
Next filing
Jun 23, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Award $0 +200K +33.33% $0.00 800K Dec 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTTA Stock Option (to acquire Common Stock) Award $0 +200K $0.00 200K Dec 20, 2021 Common Stock 200K $1.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units which shall vest into common stock of the Company over three years, subject to Dr. Marques remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches quarterly for two years thereinafter.
F2 The Reporting Person was granted 200,000 stock options. The stock options have a ten-year term and vest over three years, subject to Dr. Marques remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches quarterly for two years thereinafter.